Filing Details

Accession Number:
0001209191-22-029453
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-16 20:48:00
Reporting Period:
2022-05-16
Accepted Time:
2022-05-16 20:48:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1783183 Phathom Pharmaceuticals Inc. PHAT Pharmaceutical Preparations (2834) 824151574
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1791412 Azmi Nabulsi C/O Phathom Pharmaceuticals, Inc.
100 Campus Drive, Suite 102
Florham Pak NJ 07932
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-16 20,000 $8.16 785,700 No 4 P Indirect by Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect by Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 21,378 Direct
Common Stock 843 Indirect by 401(k)
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.00 to $8.43. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.